Lunai Bioworks (LNAI) Amortizatization of Intangibles (2013 - 2022)
Lunai Bioworks (LNAI) recorded quarterly Amortizatization of Intangibles of $70074.0 in Q1 2022, up 1.03% quarter-over-quarter from $69357.0 in Q4 2021, and down 5.65% on a YoY basis from $74274.0 in Q1 2021.
Lunai Bioworks (LNAI) Amortizatization of Intangibles (2013 - 2022) Analysis & Trends
Lunai Bioworks' Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $70074.0 for Q1 2022.
- In Q1 2022, Amortizatization of Intangibles fell 5.65% year-over-year to $70074.0; the TTM figure through Mar 2022 stood at $276061.0 (down 54.89% YoY), while the FY2021 annual figure was $267881.0, up 3.96% from the prior year.
- Amortizatization of Intangibles was $70074.0 for Q1 2022 at Lunai Bioworks, up from $69357.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $397685.0 in Q2 2020 to a low of $65981.0 in Q3 2020.
- Historically, Amortizatization of Intangibles has averaged $110997.4 across 3 years, with a median of $69715.5 in 2021.
- Biggest YoY gain for Amortizatization of Intangibles was 4.06% in 2021; the steepest drop was 82.91% in 2021.
- A 3-year view of Amortizatization of Intangibles shows it stood at $73978.0 in 2020, then fell by 6.25% to $69357.0 in 2021, then rose by 1.03% to $70074.0 in 2022.
- The last three Amortizatization of Intangibles figures came in at $70074.0 (Q1 2022), $69357.0 (Q4 2021), and $68657.0 (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 70,074.00 |
| Mar 31, 2022 | 70,074.00 |
| Dec 31, 2021 | 69,357.00 |
| Dec 31, 2021 | 69,357.00 |
| Sep 30, 2021 | 68,657.00 |
| Sep 30, 2021 | 68,657.00 |
| Jun 30, 2021 | 67,973.00 |
| Jun 30, 2021 | 67,973.00 |
| Mar 31, 2021 | 74,274.00 |
| Mar 31, 2021 | 74,274.00 |
| Dec 31, 2020 | 73,978.00 |
| Dec 31, 2020 | 73,978.00 |
| Sep 30, 2020 | 65,981.00 |
| Sep 30, 2020 | 65,981.00 |
| Jun 30, 2020 | 397,685.00 |
| Jun 30, 2020 | 397,685.00 |
| Dec 31, 2017 | 6,700.00 |
| Dec 31, 2017 | 6,700.00 |
| Sep 30, 2017 | 5,297.00 |
| Sep 30, 2017 | 5,297.00 |